Skip to content
Trial Eligibility
Menu

A Phase 2/3 Study of Brepocitinib in Adults With Lichen Planopilaris

NCT07532603

This study is recruiting at 47 US sites in 26 states, according to its ClinicalTrials.gov record last updated .

Summary

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with lichen planopilaris

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Lichen Planopilaris

Eligibility basics and study details

Study type
Interventional
Phase
Phase 2/3
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Priovant Therapeutics, Inc.
Last updated on ClinicalTrials.gov
July 8, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • Clinical Trial Site · Birmingham, AL

Arizona · 2

  • Clinical Trial Site · Phoenix, AZ
  • Clinical Trial Site · Scottsdale, AZ

California · 4

  • Clinical Trial Site · Irvine, CA
  • Clinical Trial Site · Oakland, CA
  • Clinical Trial Site · Sacramento, CA
  • Clinical Trial Site · San Francisco, CA

Colorado · 1

  • Clinical Trial Site · Denver, CO

Connecticut · 2

  • Clinical Trial Site · Farmington, CT
  • Clinical Trial Site · New Haven, CT

Florida · 1

  • Clinical Trial Site · Miami, FL

Illinois · 2

  • Clinical Trial Site · Chicago, IL
  • Clinical Trial Site · Skokie, IL

Indiana · 2

  • Clinical Trial Site · Clarksville, IN
  • Clinical Trial Site · Indianapolis, IN

Kansas · 1

  • Clinical Trial Site · Leawood, KS

Kentucky · 1

  • Clinical Trial Site · Louisville, KY

Massachusetts · 2

  • Clinical Trial Site · Boston, MA
  • Clinical Trial Site · Burlington, MA

Michigan · 2

  • Clinical Trial Site · Ann Arbor, MI
  • Clinical Trial Site · Ann Arbor, MI

Minnesota · 2

  • Clinical Trial Site · Medina, MN
  • Clinical Trial Site · Minneapolis, MN

Missouri · 2

  • Clinical Trial Site · Kansas City, MO
  • Clinical Trial Site · Lee's Summit, MO

New Hampshire · 1

  • Clinical Trial Site · Lebanon, NH

New York · 2

  • Clinical Trial Site · New Hyde Park, NY
  • Clinical Trial Site · New York, NY

North Carolina · 1

  • Clinical Trial Site · Durham, NC

Ohio · 3

  • Clinical Trial Site · Cleveland, OH
  • Clinical Trial Site · Columbus, OH
  • Clinical Trial Site · Medina, OH

Oregon · 1

  • Clinical Trial Site · Portland, OR

Pennsylvania · 1

  • Clinical Trial Site · Philadelphia, PA

South Carolina · 1

  • Clinical Trial Site · Charleston, SC

Tennessee · 2

  • Clinical Trial Site · Murfreesboro, TN
  • Clinical Trial Site · Smyrna, TN

Texas · 5

  • Clinical Trial Site · Austin, TX
  • Clinical Trial Site · Austin, TX
  • Clinical Trial Site · Cedar Park, TX
  • Clinical Trial Site · Prosper, TX
  • Clinical Trial Site · Tyler, TX

Utah · 1

  • Clinical Trial Site · Murray, UT

Virginia · 3

  • Clinical Trial Site · Norfolk, VA
  • Clinical Trial Site · Richmond, VA
  • Clinical Trial Site · Roanoke, VA

Washington · 1

  • Clinical Trial Site · Mill Creek, WA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.